Navigation Links
Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds
Date:1/13/2014

SEATTLE, Jan. 13, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that it has reached an agreement with Novartis to reacquire rights to two anti-cancer compounds -- pixantrone (PIXUVRI®) and paclitaxel poliglumex (Opaxio™). Under the terms of the previous agreement, CTI has been responsible for development and commercialization activities and expenses for both compounds to date.  Upon the effective date of termination, CTI will regain all rights that had been granted to Novartis.  In exchange for Novartis' agreement to return such rights to CTI, CTI has agreed to make certain potential payments to Novartis based on sales of Opaxio and PIXUVRI and on any sublicense and certain other amounts payable to CTI.  

"We are pleased that Novartis and CTI were able to reach a mutually beneficial agreement regarding rights to PIXUVRI and Opaxio," stated James A. Bianco, M.D., CTI's President and CEO. "Regaining full rights to these two anti-cancer agents -- one currently marketed in Europe and the other completing late-stage development -- provides us with the flexibility to manage these assets within the context of our overall product portfolio strategy. PIXUVRI is a first-in-class aza-anthracenedione with unique structural and physiochemical properties and the first approved therapy in the European Union for the treatment of patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Opaxio is completing Phase 3 development as maintenance therapy in patients with ovarian cancer and is also being studied in Phase 2 trials for patients with malignant brain cancer. We believe these drugs could have an important impact in the treatment of patients with cancer."

About PIXUVRI

PIXUVRI® (pixantrone) is a novel aza-anthracenedione with un
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco
2. PhaseRx Appoints Michael Houston, Ph.D., Vice President, Therapeutics Development
3. ImmunoCellular Therapeutics Issues Shareholder Letter Providing Update on ICT-107 Program in Newly Diagnosed Glioblastoma
4. Altheus Therapeutics announces completed enrollment of ZA201, a Phase 2 clinical trial of Zoenasa for distal ulcerative colitis
5. Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy and Immunosuppressants) - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018
6. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
7. Flexion Therapeutics Files Registration Statement for Proposed Initial Public Offering
8. G1 Therapeutics to Present at Biotech Showcase 2014
9. Daiichi Sankyo, Virtici and Celdara Medical Announce Collaboration to Identify and Progress High Potential Therapeutics
10. Mast Therapeutics Provides Enrollment Update On Phase 3 "EPIC" Study Of MST-188
11. Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... SAN FRANCISCO , July 22, 2014  Nektar Therapeutics ... for the second quarter ended June 30, 2014 on Thursday, ... Howard Robin , president and chief executive officer, will ... 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... of the conference call can be accessed through a link ...
(Date:7/22/2014)... , July 22, 2014 /PRNewswire-iReach/ -- The global ... of application, technology, portability, product, end user, price, ... register the highest growth rate in the digital ... This high growth is attributed to technological advancements ... imaging accounted for the largest share of the ...
(Date:7/22/2014)... , July 22, 2014  Edwards Lifesciences Corporation (NYSE: ... science of heart valves and hemodynamic monitoring, announced that ... today served as an expert panelist at the invitation ... on Health to discuss medical device innovation at its ... Ongoing Evidence Development and Communication." "Edwards has ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 4Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 5Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2
... Aug. 17 The hospital patient room of the future ... New Jersey, providing lessons that stand to benefit hospitals and ... building a new hospital in Plainsboro, NJ, to replace its ... a fully functioning replica of the new hospital,s proposed patient ...
... Inc. (NYSE Amex: ULU ) today announced its financial ... the second quarter of 2010, the Company reported a net loss of ... $2.9 million, or $0.04 per share, for the same period last year. ... net loss of $3.5 million, or $0.04 per share, compared with a ...
Cached Medicine Technology:Hospital Room of the Future Debuts in New Jersey 2Hospital Room of the Future Debuts in New Jersey 3Hospital Room of the Future Debuts in New Jersey 4ULURU Inc. Reports Second Quarter 2010 Financial Results 2ULURU Inc. Reports Second Quarter 2010 Financial Results 3ULURU Inc. Reports Second Quarter 2010 Financial Results 4ULURU Inc. Reports Second Quarter 2010 Financial Results 5ULURU Inc. Reports Second Quarter 2010 Financial Results 6
(Date:7/22/2014)... Midland, TX (PRWEB) July 22, 2014 ... of aging often spend a portion of their disposable ... News company is now promoting its best anti aging ... http://cherrynews.com/best-nourishing-eye-serum . , This products guide is now released ... with an Internet connection. Known retailers were selected and ...
(Date:7/22/2014)... Print Audit® has released another significant ... portal. Facilities Manager 3.1.0R includes fixes for issues ... well as numerous new reporting and alerting enhancements. ... is a powerful, easy to use managed print ... automate supplies fulfillment and report service information for ...
(Date:7/22/2014)... City, MO (PRWEB) July 22, 2014 ... Sporting Kansas City vs. Manchester City tickets at Sporting ... will take place on Wednesday, July 23rd. Tickets can ... to game time. Ticket Down can be reached toll ... vs. Manchester City are authentic and covered by Ticket Down's ...
(Date:7/22/2014)... Vitamin C is one of the elements ... to women in the United States. The Cherry News company ... online for women to review at http://cherrynews.com/best-nourishing-eye-serum . , ... one way that beauty product manufacturers are helping to introduce ... are using mixtures of Vitamins C, E and D as ...
(Date:7/22/2014)... Recently, iFitDress.com, a popular supplier of wedding dresses and special ... white party dresses to its product category. Additionally, ... available on its website. As a special offer, all customers ... get a discounted rate, up to 54% off. , A ... so its marketing specialist believes the new white party dresses ...
Breaking Medicine News(10 mins):Health News:Best Anti Aging Products Guide Launched for Natural Product Buyers Online at News Portal 2Health News:Print Audit® Releases Facilities Manager 3.1.0R 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Best Vitamin C Serum for Wrinkles List Complied for Women at Consumer News Portal Online 2Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... Tips for Days During and ... Following ... there,s smoke,and that,s not good for your respiratory health, cautions experts ... 1902. Residents far beyond the burn areas should monitor their ...
... (October 24, 2007) -- Combat physicians in war-torn areas ... predict which casualties require massive blood transfusions (MT), and ... research published in the October issue of The Journal ... that the presence of a combination of three variables ...
... Waichman Alonso LLP Announces Opening of Dedicated Claims Center To, ... Leads ... The defective Medtronic Sprint,Fidelis Defibrillator Leads were implanted into ... for serious injury if a Sprint Fidelis,Lead fractures. As a ...
... Agree to Fair Union Election Process, ORANGE, Calif., ... Jr., will be among those joining hospital,workers from Mission ... a procession Saturday outside the headquarters of the St. ... a union at SJHS hospitals have,asked the health system,s ...
... , WEDNESDAY, Oct. 24 (HealthDay News) -- British scientists say ... , They said the discovery will prove valuable to scientists ... of the study, published in the Oct. 25 issue of ... a new line of research that eventually enables researchers to ...
... of Smart Choices will provide practical advice in approaching ... a home at the annual meeting of the Institute ... Seattle. , Dr. Ralph L. Keeney, Research Professor of ... University, is co-author of Smart Choices, A Practical Guide ...
Cached Medicine News:Health News:Fire Season: Respiratory Health a Concern 2Health News:Fire Season: Respiratory Health a Concern 3Health News:Early predictive model may be new 'weapon' against leading cause of death on battlefield 2Health News:Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims 2Health News:Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims 3Health News:Trouble deciding? 2Health News:Trouble deciding? 3
... matrix constructed of cross-linked collagen fibers ... through a proprietary 360 accretion process. ... aspirate, Healos provides an excellent environment ... differentiation. The hydroxyapatite-coated collagen microfibers in ...
Sharp Weitlaner Retractor....
Weitlaner retractor, blunt....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
Medicine Products: